Lawler PR, Liu H, Frankfurter C, Lovblom LE, et al. Changes in Cardiovascular Biomarkers Associated With the Sodium-Glucose
Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney
Disease and Type 2 Diabetes. Diabetes Care 2021 Jan 12. pii: dc20-2265. doi: 10.2337/dc20-2265.
PMID: 33436398